Cefaclor

Cefaclor


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
Payment Terms
Negotiable
Production method
Negotiable
Shipping / Lead Time
Negotiable / Negotiable
Keyword
Category
Pharmaceuticals

Kyongbo Pharmaceutical Co., Ltd.

Country / Year Established
South Korea South Korea /
Business type
Others
Verified Certificate

16

TRADE TOWER

DUNS

Product name Cefaclor Certification -
Category Pharmaceuticals Ingredients -
Keyword - Unit Size -
Brand name - Unit Weigh -
origin Stock -
Supply type - HS code -

Product Information

MOLECULAR FORMULA
    C15H14ClN3O4S.H2O


MOLECULAR WEIGHT
    385.82


CAS REGISTRY NUMBER
    [70356-03-5]


Conformed to
    USP, EP, JP, KP


On processing of CEP
Registration Number ( KDMF ) : 20050831-20-A-19-03


Target
    Intermediate spectrum cephalosporins ; cell wall synthesis inhibitor


Therapeutic category
     Agents against pathologic organisms and parasites
     Cephalosporin antibiotics( 2nd generation )
     Acting mainly on gram-positive and gram-negative bacteria

 

B2B Trade

Price (FOB) Negotiable transportation -
MOQ Negotiable Leadtime Negotiable
Payment Options Negotiable Shipping time Negotiable

Kyongbo Pharmaceutical Co., Ltd.

Country / Year Established
South Korea South Korea /
Business type
Others

16

TRADE TOWER

DUNS

President
Kang, Tae Won
Address
174 Silok-ro, Asan-Si, Chungcheongnam-Do, 336-020, Korea
Product Category
Other Pharmaceutical Chemicals
No. of Total Employees
101-500
Company introduction

ISO 9001(QMS) / 14001(EMS), GMP Certification

Kyongbo Pharmaceuical Co., Ltd. is a subsidiary company of Chong Kun Dang pharmaceutical corp.  The company is a pioneer in the active pharmaceutical industry in Korea, founded in 1987, with a future-oriented outlook for fine chemistry as a promising high-tech industry for the 21st century and with the humanitarian mission to contribute to the life and health of mankind.

With its primary goal set in developing new pharmaceutical substances, the company operates under the main strategy the secure superior competitive edge by simplifying and streamlining its manufacturing procedures through technological innovation and producing highly profitable raw materials for drugs.

Main Markets

China China

Italy Italy

Japan Japan

South Korea South Korea

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My TK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more